Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 12, 2013, Pages 4295-4305

  De Castro, Ana ^a,b   Díaz, Ariana ^a   Piñeiro, Beatriz ^a   Lendoiro, Elena ^a   Cruz, Angelines ^a   López Rivadulla, Manuel ^a   Concheiro, Marta ^a,c  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Research Department Cienytech   (Spain)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Amphetamines; Cocaine; Methadone; Opioids; Placenta; Umbilical cord

Indexed keywords

DRUG PRODUCTS; EFFICIENCY; LIQUID CHROMATOGRAPHY; METABOLITES; PHASE SEPARATION;

AMPHETAMINES; COCAINE; METHADONE; OPIOIDS; PLACENTA; UMBILICAL CORDS;

EXTRACTION;

AMPHETAMINE; COCAINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ARTICLE; FEMALE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; PLACENTA; PREGNANCY; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; UMBILICAL CORD; VALIDATION STUDY;

AMPHETAMINE; ANALGESICS, OPIOID; CHROMATOGRAPHY, LIQUID; COCAINE; FEMALE; HUMANS; LIMIT OF DETECTION; METHADONE; PLACENTA; PREGNANCY; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; UMBILICAL CORD;

EID: 84886845517     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6784-6     Document Type: Article

References (32)

1. Substance Abuse and Mental Health Services Administration (SAMHSA) (2012) Results from the 2011 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-44, HHS Publication No (SMA) 12-4713
2. Finnegan LP (1985) Effects of maternal opiate abuse on the newborn. Fed Proc 44:2314-2317
3. Mayet S, Groshkova T, Morgan L, MacCormack T, Strang J (2008) Drugs and pregnancy-outcomes of women engaged with a specialist perinatal outreach addictions service. Drug Alcohol Rev 27:497-503
4. Zuckerman B, Frank D, Brown E (1995) Overview of the effects of abuse and drugs on pregnancy and offspring. NIDA Res Monogr 149:16-38
5. Gray T, Huestis M (2007) Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 388:1455-1465
6. Lozano J, Garcia-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S (2007) Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit 29:711-734
7. Bessa MA, Mitsuhiro SS, Chalem E, Barros MM, Guinsburg R, Laranjeira R (2010) Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents. Addict Behav 35:266-269
8. Huestis MA, Choo RE (2002) Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 128:20-30
9. Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA (2008) Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther 84:604-612
10. Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL (1994) Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch Pathol Lab Med 118:988-993
11. Koren G, Hutson J, Gareri J (2008) Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther 83:631-634
12. Klein J, Karaskov T, Koren G (2000) Clinical applications of hair testing for drugs of abuse-the Canadian experience. Forensic Sci Int 107:281-288
13. Concheiro-Guisan M, ShakleyaDM, HuestisMA(2009) Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal Bioanal Chem 394:513-522
14. de Castro A, Concheiro M, Shakleya DM, Huestis M (2009) Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J Anal Toxicol 33:243-252
15. Joya X, Pujadas M, Falcon M, Civit E, Garcia-Algar O, Vall O, Pichini S, Luna A, de la Torre R et al (2010) Gas chromatography-mass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation. Forensic Sci Int 196:38-42
16. Marin SJ, Christensen RD, Baer VL, Clark CJ, McMillin GA (2010) Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Ther Drug Monit 33:80-85
17. Winecker RE, Goldberger BA, Tebbett I, Behnke M, Eyler FD, Conlon M, Wobie K, Karlix J, Bertholf RL (1997) Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J Anal Toxicol 21:97-104
18. Moore CM, Brown S, Negrusz A, Tebbett I, Meyer W, Jain L (1993) Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: a case study. J Anal Toxicol 17:62
19. Jones J, Rios R, Jones M, Lewis D, Plate C (2009) Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:3701-3706
20. Concheiro M, Shakleya DM, Huestis MA (2009) Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphineglucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry. Forensic Sci Int 188:144-151
21. de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA (2011) Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit 33:443-452
22. de Castro A, Concheiro M, Shakleya DM, Huestis MA (2009) Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord. J Chromatogr B Analyt Technol Biomed Life Sci 877:3065-3071
23. de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA (2011) Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin Chem 57:449-458
24. Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA (2010) Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther Drug Monit 32:206-215
25. Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA (2010) Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes. J Anal Toxicol 34:498-505
26. The Commission of the European Communities (2002) Commision decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Commun L 221:8-36
27. Krouwer JS, Rabinowitz R (1984) How to improve estimates of imprecision. Clin Chem 30:290-292
28. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019-3030
29. ElSohly MA, Kopycki W, Feng S, Murphy TP (1999) Identification and analysis of the major metabolites of cocaine inmeconium. J Anal Toxicol 23:446-451
30. Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA (2010) Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction 105:2151-2159
31. Nanovskaya TN, Deshmukh SV, Nekhayeva IA, Zharikova OL, Hankins GD, Ahmed MS (2004) Methadone metabolism by human placenta. Biochem Pharmacol 68:583-591
32. Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Huestis MA (2010) Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction 105:2151-2159